Located at 2701 Chestnut Station Court in a Jeffersontown industrial park off Blankenbaker Parkway, the 41,000-square-foot facility, named Norton Pharmacy – Blankenbaker, officially opened on July 20. Healthcare leaders gathered on Aug. 13 for a formal ribbon-cutting ceremony to celebrate the milestone investment.

Enhanced Centralized Fulfillment and Patient Services

The centralized hub operates as both a full-service retail pharmacy for walk-in pickups and vaccinations and as the organization’s high-volume central fill operation. Managed by Norton Pharmacy pharmacists, the facility uses 12 automated dispensing robots, automated conveyor systems, and RFID tracking-enabled equipment to prepare thousands of prescriptions daily.

The system is capable of processing up to 7,000 prescriptions during a single eight-hour shift. Centralizing the preparation of retail prescriptions allows Norton Healthcare to standardize consistency and accuracy across its network.

“We’re so proud of this facility because there is no reason going forward that any of our patients don’t have an easy way to get access to the medication that they need,” said Russell Cox, president and CEO of Norton Healthcare.

Expanding Regional Access with Home Delivery

For the first time in the 140-year history of Norton Healthcare, the health system is offering free home delivery for prescriptions to patients across Kentucky and Indiana. While the system aims for delivery within 72 hours of a prescription being issued, initial operations have achieved an average turnaround time of approximately 28 hours.

“After years of having to travel a long distance for my prescriptions, I am thrilled for the option of home delivery,” said Vanta Lewis, a patient who spoke at the ribbon cutting. “This additional pharmacy creates convenience and access for patients across the region.”

Strategic Location and Operational Growth

Norton Healthcare acquired the property in July 2025 and brought the location online within one year. Positioned less than a mile from the future 150-acre Norton Children’s pediatric campus, the site fits strategically into ongoing expansion plans in Jeffersontown.

“We know that we have more growth in the J-Town area, so this was really kind of an ideal situation,” said Amanda Castle, system vice president of pharmacy services at Norton Healthcare.

The automated pharmacy currently operates with 30 full-time equivalent employees on a single shift. Operations are expected to expand within the next five years to include a second shift and dozens of additional staff members as patient adoption grows.

This operational transition reflects a broader regional trend among healthcare providers seeking to increase medication accessibility. Competitor Baptist Health opened a centralized pharmacy facility two years ago in June.

“We talk a whole lot in healthcare about new treatments, new discoveries, new whiz bang ways to do things and what we miss sometimes, if we would just improve the process for the wonderful things that we already have, that removes the friction from patients and it will make for better outcomes,” Cox noted. “This is the best example of that.”

By automating repetitive filling tasks, the health system intends to free up pharmacists to focus on direct patient care across clinical settings.

“At the end of the day every prescription represents a patient, someone who needs to get their medication … and have their healthcare team make that process a little bit easier,” Castle said. “That’s really what this pharmacy is about. …The goal is to ensure our (teams) can spend more time providing the personal care that our patients deserve.”

The initiative integrates the Rapid Enterprise Platform into hospital imaging systems and care workflows across the health system’s regional network. The software connects directly with picture archiving and communication systems (PACS), electronic health records (EHRs), care-team tools, and clinical worklists to optimize hospital imaging protocols.

Systemwide Network Integration and Care Coordination

The implementation supports stroke imaging across multiple modalities, including non-contrast computed tomography (NCCT), computed tomography angiography (CTA), and computed tomography perfusion (CTP). By expanding the technology systemwide, OSF HealthCare aims to connect rural facilities with specialized expertise at its comprehensive stroke centers located at OSF HealthCare Saint Francis Medical Center in Peoria and OSF HealthCare Saint Anthony Medical Center in Rockford.

Initial use of the platform at select hospitals produced improvements in treatment times and provided more consistent identification of patients who could benefit from specialized stroke interventions. Time efficiency remains critical during acute events, as data from the American Stroke Association indicates that nearly 2 million brain cells die every minute a stroke goes untreated.

Clinical Workflow Software and Regulatory Clearance

“The sooner we can get these images,” Talkad said, “that can save minutes.” Arun Talkad, who directs stroke care at OSF HealthCare Saint Francis Medical Center in Peoria, emphasized that rapid access to high-quality stroke imaging helps reduce delays between initial evaluation and clinical decision-making.

The RapidAI platform distributes image findings and automated analysis directly to medical teams through workstation, desktop, and mobile tools, enabling clinicians to review case images and communicate in real time across the care journey. The software serves as a triage support tool designed to assist care teams rather than replace physician judgment.

The U.S. Food and Drug Administration (FDA) cleared Rapid NCCT Stroke, a RapidAI product, as radiological computer-aided triage and notification software designed to analyze head CT scans and alert clinicians to suspected findings. This systemwide rollout demonstrates how regional healthcare providers are incorporating specialized stroke care AI into standardized clinical workflows to deliver consistent care across all facilities.

Addressing Fragmented Datasets and Data Governance

The strategic alliance addresses a longstanding challenge for healthcare providers, where patient, clinical, and operational data resides in isolated systems. By linking these fragmented datasets, the joint effort improves data governance and creates unified data structures required to support AI in daily administrative tasks and operational workflows. Under the terms of the agreement, Mastek will deploy and adapt Innovaccer’s healthcare AI platform in existing and new markets, utilizing platform capabilities designed for interoperability and AI agent deployment.

Innovaccer’s platform is currently utilized across value-based care, population health, revenue cycle management, patient access, and operational workflows. The arrangement combines Mastek’s capabilities in platform migration, digital front door services, AI-based chat, and conversational agent deployment with Innovaccer’s specialized AI agents for scheduling and referrals.

UK Expansion and International Delivery Reach

In the UK market, the agreement builds directly on Mastek’s established track record of delivering technology initiatives for the NHS. This provides Innovaccer a dedicated route into a sector where health systems face continuous pressure to modernise legacy data infrastructure while expanding patient access, back-office efficiency, and service coordination. Mastek operates across more than 40 countries with over 4,700 specialists and serves more than 275 healthcare and life sciences customers globally, including providers, payers, pharmaceutical businesses, medical device companies, and public health organisations.

For Innovaccer, this healthcare AI partnership supports expansion across European and UK markets by adding Mastek’s delivery presence to its established footprint in the US and Middle East. The agreement also places Mastek in Innovaccer’s Platinum GSI programme, a partner group of global systems integrators building specialized delivery practices around Innovaccer’s Gravity platform for large-scale digital transformation projects.

Executive Leadership Comments

Umang Nahata, Chief Executive Officer at Mastek, outlined the company’s objective regarding the collaboration:

“Healthcare organisations need AI that is simple, trusted and built on connected data. Our Platinum partnership with Innovaccer strengthens Mastek’s ability to help customers turn healthcare data into actionable intelligence and accelerates our journey to become a leading AI transformation partner for the healthcare industry,” said Umang Nahata, Chief Executive Officer, Mastek.

Abhinav Shashank, Co-Founder and Chief Executive Officer at Innovaccer, highlighted the significance of the integration:

“When leading healthcare-focused global systems integrators independently choose to build their delivery practices around Gravity, it tells the market that this platform is trusted to carry the most complex, high-stakes healthcare transformation programs in the world. Mastek joining our Platinum GSI program is a validation of that, and it gives us something we could not build quickly on our own – four decades of institutional relationships with health systems and governments across three continents. Together, we are bringing autonomous healthcare operations to markets where the ambition has always been there and the right platform and delivery partner have not been until now,” said Abhinav Shashank, Co-Founder and Chief Executive Officer, Innovaccer.

Industry Landscape and Technological Alignment

The partnership aligns with a widespread industry movement toward enterprise-wide data unification rather than isolated software implementations. Many health systems, hospitals, and public health bodies continue to rely on legacy environments that hinder fluid data sharing, limiting the effectiveness of advanced analytics and generative AI applications. Addressing data quality and structure remains critical as adoption of automated agents and operational tools expands across healthcare administration.

By pairing a dedicated data platform with an experienced systems integrator, both companies aim to accelerate digital transformation while resolving data governance hurdles across administrative and operational workflows worldwide.

The platform is structured to address critical bottlenecks in rare disease diagnosis where standard analytical methods struggle to categorize novel DNA variants. By integrating genomic sequencing data alongside patient phenotypes, OneGenome functions as an advanced decision-support tool designed to aid specialists in precision medicine applications without replacing clinical judgment. In July 2026, the innovation received an Innovate for Impact Use Case Award from the International Telecommunication Union at the UN AI for Good Global Summit.

Model Architecture and Comparative Benchmarks

The underlying Genos foundation model processes long DNA sequences from diverse populations. By linking these biological findings with medical literature, the genomic AI system enables structured reasoning over complex variant data. Developers report that OneGenome has surpassed conventional gene models and general-purpose artificial intelligence tools across several diagnostic and medication-guidance benchmarks.

Similar analytical methodologies are being explored across the sector. For instance, researchers at Shanghai Jiao Tong University and Xinhua Hospital introduced DeepRare, a platform that pairs clinical phenotypes with genetic context. In research testing published in Nature, DeepRare achieved a 57.18% top-ranked diagnostic rate using phenotype data alone, which rose above 70% when whole-genome or exome information was incorporated.

Diagnostic Impact and Scientific Considerations

Evaluating massive genomic datasets remains a primary challenge for clinical teams. Broader studies highlight the potential of comprehensive genetic analysis; a 2024 Nature Genetics study reported that genome sequencing provided plausible diagnostic answers for 29.3% of participants with suspected rare conditions. Furthermore, a 2025 study of 1,452 Korean families demonstrated a 46.2% molecular diagnostic yield, which altered clinical management in 18.5% of diagnosed cases.

Despite these computational advancements, developers emphasize that OneGenome is not an autonomous diagnostic entity. Variant interpretation requires thorough contextualization against clinical symptoms, population frequencies, and patient family histories. Precision medicine initiatives, including the NIH Undiagnosed Diseases Program, continue to demonstrate that computational outputs must be validated through clinical evaluation, rigorous privacy safeguards, and expert specialist oversight before broad integration into routine healthcare.

These FDA clearances support the company’s efforts to help clinical laboratories transition beyond basic digitization into fully connected, standardized, and scalable diagnostic workflows. The updated portfolio introduces Aperio iQC DX software, adds the Aperio GT 180 DX scanner, and incorporates enhanced features for the Aperio GT 450 DX scanner.

AI-Assisted Quality Control Software for Clinical Workflows

The newly cleared Aperio iQC DX software is the industry’s first FDA 510(k)-cleared quality control software designed for AI-assisted digital pathology in a clinical environment. Whole slide images are frequently subject to quality issues caused during tissue preparation, staining, coverslipping, or scanning. These issues include air bubbles, pen marks, clipped tissue, missing tissue, out-of-focus regions, and image striping.

By automatically detecting these six common slide artifacts while slides remain on the scanner, the software allows laboratories to recognize and resolve potential quality issues earlier in the process. This automated capability reduces the necessity for rescanning or rework, limits downstream delays, and promotes reproducible image review.

In a real-world data study conducted with the Institute of Pathology at Heidelberg University, the AI models identified up to 24% more artifacts missed by histotechnicians and reduced hands-on review time by 69%, enabling laboratories to reallocate skilled personnel to higher-value operational tasks.

Expanding Clinical Scanning Capabilities Across Laboratories

To accommodate diverse laboratory caseloads, Leica Biosystems is extending its clinical scanning systems. The high-throughput Aperio GT 450 DX clinical scanner, which features a 450-slide capacity and small operational footprint, now includes new manual scan capabilities for complex slides, advanced DICOM capabilities, and z-stacking functionality for clinical environments.

Additionally, the company has added the Aperio GT 180 DX clinical scanner to serve mid-volume laboratories. Featuring a 180-slide capacity alongside the same scanning speeds and core feature set as the GT 450 DX, the GT 180 DX assists laboratories in constructing streamlined clinical scanning procedures tailored to their specific operational needs and staffing models, furthering connected diagnostic workflows across institutions.

“Every improvement in the pathology workflow matters because patients and clinicians are waiting for answers that guide care,” said Naveen Chandra, Vice President and General Manager of Digital Pathology at Leica Biosystems. “These FDA 510(k) clearances demonstrate Leica Biosystems’ leadership in advancing digital pathology beyond individual products toward connected, standardized workflows that help laboratories operate with greater confidence and consistency. By embedding AI-assisted quality control directly into the scanning workflow and expanding clinical scanning options, we are enabling laboratories to scale digital pathology in ways that support timely diagnosis, pathologist efficiency and better care for patients.”

As part of Danaher’s connected ecosystem of life sciences and diagnostics companies, Leica Biosystems supports nearly 2 million cancer tests globally each week, providing end-to-end solutions spanning from initial biopsy to final diagnosis.

Addressing Operational and Regulatory AI Demands

As healthcare systems accelerate technology transformation, managing the expansion of healthcare AI across clinical workflows and operational systems requires new oversight frameworks. Vitea’s platform equips Mercyhealth with centralized policy orchestration, continuous drift monitoring, and performance oversight tailored for complex multi-site clinical operations spanning northern Illinois and southern Wisconsin.

The system deploys over 100 out-of-the-box healthcare-specific policies that operate in real time across every prompt and response. This structure ensures that rapidly expanding technology initiatives protect patient safety and maintain data integrity across all care locations.

“At Mercyhealth, we’ve always held ourselves to a high bar when it comes to technology and security,” said Ali Olia, Chief Information Officer at Mercyhealth. “But AI introduces a new category of risk that traditional security tools simply weren’t built to address. These are non-deterministic systems — they don’t behave the same way twice — and that requires a fundamentally different approach to governance. Vitea gives us the infrastructure to stay ahead of that risk and continue innovating boldly.”

Strengthening Patient Safety and Oversight

Operating across multiple states with differing regulatory standards, Mercyhealth required a central infrastructure capable of maintaining unified compliance. The implementation of Vitea allows deviations in model behavior to be identified early in the clinical workflow, safeguarding data integrity and operational consistency.

“The moment AI touches patient care, the bar for data integrity and accountability goes up significantly,” said Jeremy Colson, Chief Data and Analytics Officer at Mercyhealth. “With Vitea, we have visibility into how our AI applications are performing and the ability to enforce policy across them, so deviations surface early rather than after the fact. For a health system at our scale, that level of oversight isn’t optional.”

Embedding Governance into Strategy

The partnership highlights an industry-wide evolution toward integrating a dedicated AI governance platform directly into core technology strategies, prioritizing long-term patient safety while advancing clinical efficiency.

Shantanu Nigam, CEO of Vitea, said, “Mercyhealth is building and adopting real AI capabilities, both through partners and in-house applications. They understand the risks and they are committed to doing this right for their patients, their staff, and their communities. We built Vitea for organizations like this: forward-thinking teams that want to move fast without leaving governance behind. We are proud to be their partner.”

The joint initiative addresses the operational gap between modern technology investments and total cost of care reduction. By combining PwC’s healthcare consulting, operations, and transformation capabilities with Zyter|TruCare’s Vertical AI Execution Platform, agentic AI orchestration engine (Zyter Symphony), and clinical services, the partnership seeks to convert enterprise software assets into governed operational execution.

Addressing Systemic Operational Challenges

The collaboration targets persistent structural issues facing health plans and health systems, including rising medical expenses, administrative overhead, workforce constraints, and fragmented data. Despite significant investments in upgrading legacy enterprise systems, clinical and administrative functions such as utilization management, care coordination, and appeals processing frequently rely on manual and reactive processes.

To resolve these friction points, the partnership embeds governed, auditable, and API-native artificial intelligence directly into daily operational workflows. The scope of core administrative and clinical workflows covered includes:

• Utilization management and care management triage
• Appeals and grievances processing
• Comprehensive care coordination across legacy systems of record

Vertical AI Orchestration and Integration

The technical framework pairs business process redesign with automated software orchestration. Zyter Symphony and Praxis Orchestration function as a vertical AI execution plane operating across legacy transactional cores, including claims, electronic health records (EHR), and customer relationship management (CRM) platforms. The software automates complex multi-system workflows while enforcing policy guidelines and maintaining decision auditability.

Modular API integration allows native connectivity into existing transactional platforms, including Zyter’s TruCare foundation or third-party enterprise systems, to capture real-time clinical and financial data. Complementing this technology, PwC provides operational assessments, operating models redesign, analytics governance, and change management to align workflow automation with quantifiable financial and clinical performance.

Leadership and Strategic Vision

Executive leadership for the initiative includes Thom Bales, National Health Services Advisory Leader at PwC US, and Sundar Subramanian, CEO of Zyter. The joint efforts are structured to assist healthcare organizations in moving away from high-friction manual management toward policy-compliant, proactive automation.

“Healthcare organizations are under intense pressure to improve outcomes while reducing total cost of care, and that requires more than technology implementation,” said Thom Bales, National Health Services Advisory Leader at PwC US. “Working with Zyter|TruCare, we can help health organizations redesign operating models, embed governed AI into clinical and administrative workflows, and turn transformation programs into measurable performance improvement.”

Through these integrated measures, the alliance supports broader industry efforts to optimize care cost management while enhancing operational efficiency across enterprise healthcare systems.

The deal is expected to close in the third quarter of 2026, subject to standard regulatory review. Owen Tripp, CEO of Included Health, noted that the goal is to merge Firefly’s clinically integrated health plan with Included Health’s AI-native navigation and clinical scale. “Over time, the goal is to bring together Firefly’s clinically integrated health plan with Included Health’s AI-native navigation, clinical platform, and scale to create a single, connected benefits experience for employers and members nationwide,” Tripp stated. He added that the combination is designed to integrate plan design, administration, and comprehensive care to reduce friction and improve employee health.

Strategic Integration of Primary Care and Navigation

The acquisition follows Included Health’s recent launch of a new plan design centered on primary care and transparent upfront costs. This model leverages an AI assistant named Dot for 24/7 member support, ensuring that patients can access immediate answers or be seamlessly transitioned to human support when necessary. By incorporating Firefly’s ecosystem—which includes more than 2,300 in-person, in-home, and specialty partners—Included Health can offer a more robust infrastructure for alternative health plans. This architecture aligns financial incentives so that high-quality, primary care-led interventions become the most affordable choice for both the employer and the member.

Firefly Health CEO Fay Rotenberg highlighted that the traditional healthcare model often fails to deliver the results employers require, necessitating a shift toward dynamic plan design. “Firefly flips the traditional model on its head. We’ve built a true health plan alternative where advanced primary care, data-driven navigation, and dynamic plan design work in harmony,” Rotenberg stated. She observed that together with Included Health, the organization is bringing a trust-first model to a national stage, providing the technology and clinical reach required to serve employers across various geographies.

Addressing Rising Healthcare Costs for Employers

The move comes at a time when employers are facing record-high healthcare expenditures. According to data from the Business Group on Health, approximately 17% of employers have already adopted non-traditional or alternative health plans, with another 36% considering such models for the near future. Included Health’s strategy aims to leverage network optimization and a concierge member experience to create a sustainable path to long-term savings. Tripp emphasized the shared belief that investing in primary care and navigating members toward high-quality providers are the primary levers for reducing unnecessary medical costs while maintaining access to essential services.

While the financial terms of the acquisition were not disclosed, the combined entity is positioned to provide a unified benefits experience that simplifies administration for HR leaders. By bringing together care delivery and plan architecture, the partnership seeks to deliver clinical and financial results that follow naturally from aligned incentives. As the healthcare industry continues to move toward value-based models, the integration of Firefly Health into the Included Health platform represents a significant expansion of the available tools for employers seeking to modernize their health benefit offerings and stabilize their long-term clinical outcomes.

Under the terms of the agreement, Siemens Healthineers will serve as the primary provider of advanced technology for a wide range of clinical departments. This includes the provision of hardware and software for magnetic resonance imaging (MRI), computed tomography (CT), molecular imaging, and interventional radiology. Additionally, the partnership incorporates Varian radiation oncology systems for Vanderbilt University Hospital, Monroe Carell Jr. Children’s Hospital at Vanderbilt, and other affiliated sites. This commitment to healthcare technology modernization is intended to strengthen Vanderbilt Health’s patient-centered approach to personalized care delivery and improve health outcomes for diverse communities.

Enhancing Clinical Innovation and AI Integration

The collaboration extends beyond traditional equipment replacement, as both organizations will explore new opportunities in data infrastructure and AI-enabled technologies. Specifically, the partnership will investigate scalable artificial intelligence uses in radiology, personalized medicine, and workflow automation. These efforts are designed to support clinical teams by reducing administrative burdens and developing care models that can be applied more broadly across the health system. Jane Freedman, MD, Deputy Chief Executive Officer for Vanderbilt Health, observed: “Our mission is to continually provide patients first access to the very latest advancements. Joining with Siemens Healthineers will help our health system remain on the cutting edge regarding imaging technology implementation while also offering access to their other innovations.”

The Value Partnership model is designed to reduce operational complexity while creating measurable clinical value. By integrating advanced imaging and radiation oncology technology with operational expertise, the framework helps healthcare providers anticipate future needs while improving current care delivery. John Kowal, President and Head of the Americas at Siemens Healthineers, noted that the commitment to patient-centered care and research leadership makes Vanderbilt Health an ideal partner for this framework of innovation. The agreement also includes related workforce development programs, ensuring that hospital staff are adequately trained to leverage the full potential of the newly implemented digital and clinical technologies.

Strategic Advancements in Public Healthcare

Held at the Silk Road General Hospital in the Ethiopian capital, the launch brought together senior Ethiopian government officials, members of the Chinese diplomatic community, alongside African and Chinese medical professionals. Addressing the attendees, Ethiopian President Taye Atske Selassie underscored the necessity of integrating modern technology and a proficient health workforce into public health services. He stated that adopting advanced medical techniques enables efficient service delivery to Ethiopian communities and across the African continent.

The president commended Chinese trainers and doctors for their commitment to skill and knowledge transfer, stating they are “important in upgrading our health services, appointing ourselves with new technology, and to be pioneers in many ways.”

Cultivating Specialized Medical Expertise

These collaborative initiatives aim to foster long-term cooperation between Chinese and African institutions by developing a localized workforce of African specialists. This structural enhancement will be achieved through systematic mentoring, simulator-based training, and practical clinical instruction focusing on advanced endoscopic technology and robotic surgical techniques.

Chinese Ambassador to Ethiopia Chen Hai characterized the initiative as a concrete step in executing the Health Partnership Action under the Forum on China-Africa Cooperation.

“At a time when practical cooperation between China and Africa continues to deepen and deliver tangible results across many sectors, I am especially pleased to see more of China’s high-quality medical expertise and resources reaching Africa, and Ethiopia in particular,” he said.

Promoting Sustainable Healthcare Equity

Ethiopian Health Minister Mekdes Daba praised the mutually beneficial outcomes of the collaborative frameworks in the health sector. Emphasizing the need for medical excellence, she noted that the joint initiatives “will become a model of success that we will try to translate to other services.”

According to Liu Longfei, vice president of Xiangya Hospital of Central South University, minimally invasive surgery plays a crucial role in advancing healthcare equity by providing precise treatment, reducing trauma, accelerating recovery times, and enhancing safety for surgical patients. He noted that institutions under the China-Africa Hospital Alliance are establishing long-term collaborative mechanisms to facilitate knowledge sharing and talent exchange. Promoting healthcare equity remains a central objective as these institutions expand access to minimally invasive surgery across the region.

During the inaugural session, approximately 40 trainees from Sudan, Tanzania, Uganda, Ghana, Libya, and Ethiopia participated in the primary training program centered on endoscopic technology, which was conducted by Chinese experts. This specialized instruction also introduced foundational principles for mastering robotic surgical techniques, reinforcing the overall goals of the medical partnership.